Our Product Pipeline

Botanix’s product pipeline includes three advanced clinical programs which are leveraging synthetic cannabidiol in the topical treatment of serious skin diseases and for antimicrobial applications. Botanix also has an active discovery chemistry program to identify, synthesise, and test novel chemical entities that are structurally related to naturally occurring cannabinoids.

Indication Product Phase 1 Phase 1b Phase 2 Phase 3 Status
Moderate to severe acne BTX 1503
Pending Phase 3 study
Rosacea BTX 1702
Phase 2b study underway
Atopic dermatitis BTX 1204A
Canine proof-of-concept study underway
Antimicrobial BTX 1801
Phase 2b study (successfully completed).
Phase 2b study (pending).